Inizio
Inizio, a leading global healthcare services company, is headquartered in Ireland (IE) and operates extensively across Europe and North America. Founded in 2021, Inizio has quickly established itself in the healthcare industry, focusing on areas such as medical communications, commercialisation, and patient engagement. The company offers a unique suite of services designed to enhance the effectiveness of healthcare brands, leveraging innovative strategies and data-driven insights. Notable for its commitment to excellence, Inizio has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical and biotechnology companies. With a strong emphasis on collaboration and tailored solutions, Inizio continues to redefine the landscape of healthcare services, ensuring impactful outcomes for clients and patients alike.
DitchCarbon Score
How does Inizio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Inizio's score of 48 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Inizio's reported carbon emissions
Inizio Group Limited, headquartered in Ireland, reported significant carbon emissions in recent years. In 2023, the company emitted approximately 38,074,000 kg CO2e, with Scope 1 emissions at about 5,919,000 kg CO2e, Scope 2 emissions at approximately 1,945,000 kg CO2e, and Scope 3 emissions reaching around 30,210,000 kg CO2e. This marked a notable increase from 2022, where total emissions were about 50,753,000 kg CO2e. Inizio has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 46.2% by 2031, using 2021 as the baseline year. Additionally, the company plans to cut Scope 3 emissions from purchased goods and services, fuel- and energy-related activities, and business travel by 27.5% within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C. In summary, Inizio is actively working towards substantial reductions in its carbon footprint, demonstrating a commitment to sustainability and climate action in the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 22,734,000 | 0,000,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 11,122,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,173,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Inizio is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
